{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T23:40:46Z","timestamp":1789688446100,"version":"4.0.1"},"reference-count":70,"publisher":"Impact Journals, LLC","issue":"34","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncotarget"],"published-print":{"date-parts":[[2018,5,4]]},"DOI":"10.18632\/oncotarget.25169","type":"journal-article","created":{"date-parts":[[2018,5,4]],"date-time":"2018-05-04T12:56:54Z","timestamp":1525438614000},"page":"23373-23389","source":"Crossref","is-referenced-by-count":48,"title":["Fenfluramine diminishes NMDA receptor-mediated seizures via its mixed activity at serotonin 5HT2A and type 1 sigma receptors"],"prefix":"10.18632","volume":"9","author":[{"given":"Mar\u00eda","family":"Rodr\u00edguez-Mu\u00f1oz","sequence":"first","affiliation":[{"name":"Neuropharmacology, Department of Translational Neurosciences, Cajal Institute, CSIC, Madrid E-28002, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pilar","family":"S\u00e1nchez-Bl\u00e1zquez","sequence":"additional","affiliation":[{"name":"Neuropharmacology, Department of Translational Neurosciences, Cajal Institute, CSIC, Madrid E-28002, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javier","family":"Garz\u00f3n","sequence":"additional","affiliation":[{"name":"Neuropharmacology, Department of Translational Neurosciences, Cajal Institute, CSIC, Madrid E-28002, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"7892","published-online":{"date-parts":[[2018,5,4]]},"reference":[{"key":"1","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/S0031-6997(24)01394-2","article-title":"The glutamate receptor ion channels","volume":"51","author":"Traynelis","year":"1999","journal-title":"Pharmacol Rev"},{"key":"2","doi-asserted-by":"crossref","first-page":"3413","DOI":"10.1523\/JNEUROSCI.14-06-03413.1994","article-title":"Cellular and molecular basis of epilepsy","volume":"14","author":"McNamara","year":"1994","journal-title":"J Neurosci"},{"key":"3","first-page":"25","article-title":"Excitatory amino acids in epilepsy","volume":"13","author":"Turski","year":"1998","journal-title":"Restor Neurol Neurosci"},{"key":"4","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.seizure.2015.05.010","article-title":"Ketamine for the treatment of refractory status epilepticus","volume":"30","author":"Wang","year":"2015","journal-title":"Seizure"},{"key":"5","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1016\/S0140-6736(00)40184-4","article-title":"On a particular form of infantile convulsions","volume":"1","author":"West","year":"1841","journal-title":"Lancet"},{"key":"6","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/j.1528-1167.2011.02994.x","article-title":"The core Dravet syndrome phenotype","volume":"52","author":"Dravet","year":"2011","journal-title":"Epilepsia"},{"key":"7","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.pediatrneurol.2011.11.003","article-title":"Genes of early-onset epileptic encephalopathies: from genotype to phenotype","volume":"46","author":"Leuzzi","year":"2012","journal-title":"Pediatr Neurol"},{"key":"8","doi-asserted-by":"crossref","first-page":"S7","DOI":"10.1111\/j.1528-1157.1993.tb04593.x","article-title":"The Lennox-Gastaut syndrome","volume":"34","author":"N\u2019Guyen","year":"1993","journal-title":"Epilepsia"},{"key":"9","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/j.0013-9580.2004.05001.x","article-title":"Basic science behind the catastrophic epilepsies","volume":"45","author":"Rho","year":"2004","journal-title":"Epilepsia"},{"key":"10","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1016\/S0301-0082(97)00092-0","article-title":"Pharmacology of glutamate receptor antagonists in the kindling model of epilepsy","volume":"54","author":"Loscher","year":"1998","journal-title":"Prog Neurobiol"},{"key":"11","first-page":"476","article-title":"High doses of memantine (1-amino-3,5-dimethyladamantane) induce seizures in kindled but not in non-kindled rats","volume":"341","author":"Honack","year":"1990","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"12","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1007\/BF00633204","article-title":"Anticonvulsant action of 1,3-dimethyl-5-aminoadamantane. Pharmacological studies in rodents and baboon, Papio papio","volume":"332","author":"Sontag","year":"1986","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"13","doi-asserted-by":"crossref","first-page":"56","DOI":"10.5698\/1535-7511-11.2.56","article-title":"Revisiting AMPA receptors as an antiepileptic drug target","volume":"11","author":"Rogawski","year":"2011","journal-title":"Epilepsy Curr"},{"key":"14","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1136\/bmj.2.5514.624","article-title":"Treatment of refractory obesity with fenfluramine","volume":"2","author":"Duncan","year":"1966","journal-title":"Br Med J"},{"key":"15","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1177\/1756285615607726","article-title":"Low-dose fenfluramine in the treatment of neurologic disorders: experience in Dravet syndrome","volume":"8","author":"Ceulemans","year":"2015","journal-title":"Ther Adv Neurol Disord"},{"key":"16","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1111\/j.1528-1167.2012.03495.x","article-title":"Successful use of fenfluramine as an add-on treatment for Dravet syndrome","volume":"53","author":"Lagae","year":"2012","journal-title":"Epilepsia"},{"key":"17","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1007\/BF00547426","article-title":"Pharmacokinetics of fenfluramine and norfenfluramine in volunteers given D- and DL-fenfluramine for 15 days","volume":"29","author":"Garattini","year":"1985","journal-title":"Eur J Clin Pharmacol"},{"key":"18","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S0026-895X(24)26444-0","article-title":"Possible role of valvular serotonin 5-HT(2B) receptors in the cardiopathy associated with fenfluramine","volume":"57","author":"Hollis","year":"2000","journal-title":"Molecular Pharmacology"},{"key":"19","doi-asserted-by":"crossref","first-page":"2836","DOI":"10.1161\/01.CIR.102.23.2836","article-title":"Evidence for possible involvement of 5-HT(2B) receptors in the cardiac valvulopathy associated with fenfluramine and other serotonergic medications","volume":"102","author":"Roth","year":"2000","journal-title":"Circulation"},{"key":"20","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1007\/s00221-013-3757-0","article-title":"The role of different serotonin receptor subtypes in seizure susceptibility","volume":"232","author":"Rahimian","year":"2014","journal-title":"Exp Brain Res"},{"key":"21","doi-asserted-by":"crossref","first-page":"1766","DOI":"10.1089\/ars.2012.5100","article-title":"Cannabinoid receptors couple to NMDA receptors to reduce the production of NO and the mobilization of zinc induced by glutamate","volume":"19","author":"Garz\u00f3n","year":"2013","journal-title":"Antioxid Redox Signal"},{"key":"22","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/j.neuropharm.2005.03.019","article-title":"Muscarinic receptor stimulation reduces NMDA responses in CA3 hippocampal pyramidal cells via Ca2+-dependent activation of tyrosine phosphatase","volume":"49","author":"Gerber","year":"2005","journal-title":"Neuropharmacology"},{"key":"23","doi-asserted-by":"crossref","first-page":"5488","DOI":"10.1523\/JNEUROSCI.1187-05.2005","article-title":"Serotonin 5-HT1A receptors regulate NMDA receptor channels through a microtubule-dependent mechanism","volume":"25","author":"Yan","year":"2005","journal-title":"J Neurosci"},{"key":"24","doi-asserted-by":"crossref","first-page":"18338","DOI":"10.1073\/pnas.0604560103","article-title":"Adrenergic modulation of NMDA receptors in prefrontal cortex is differentially regulated by RGS proteins and spinophilin","volume":"103","author":"Yan","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"key":"25","first-page":"840","article-title":"Dopamine D(1) and D(3) receptors oppositely regulate","volume":"103","author":"Xu","year":"2007","journal-title":"J Neurochem"},{"key":"26","doi-asserted-by":"crossref","first-page":"9852","DOI":"10.1523\/JNEUROSCI.23-30-09852.2003","article-title":"Regulation of NMDA receptors by dopamine D4 signaling in prefrontal cortex","volume":"23","author":"Yan","year":"2003","journal-title":"Journal of Neuroscience"},{"key":"27","doi-asserted-by":"crossref","first-page":"10265","DOI":"10.1074\/jbc.M111.325175","article-title":"Regulation of N-methyl-D-aspartic acid (NMDA) receptors by metabotropic glutamate receptor 7","volume":"287","author":"Yan","year":"2012","journal-title":"J Biol Chem"},{"key":"28","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1038\/nrn1368","article-title":"Src kinases: a hub for NMDA receptor regulation","volume":"5","author":"Kalia","year":"2004","journal-title":"Nat Rev Neurosci"},{"key":"29","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1038\/7243","article-title":"G-protein-coupled receptors act via protein kinase C and Src to regulate NMDA receptors","volume":"2","author":"MacDonald","year":"1999","journal-title":"Nat Neurosci"},{"key":"30","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1124\/mol.112.083352","article-title":"Ionotropic glutamate receptors: regulation by G-protein-coupled receptors","volume":"83","author":"Dingledine","year":"2013","journal-title":"Molecular Pharmacology"},{"key":"31","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/0896-6273(91)90270-A","article-title":"Sustained potentiation of NMDA receptor-mediated glutamate responses through activation of protein kinase C by a \u03bc opioid","volume":"7","author":"Huang","year":"1991","journal-title":"Neuron"},{"key":"32","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1126\/science.294.5544.1024","article-title":"The neurobiology of slow synaptic transmission","volume":"294","author":"Greengard","year":"2001","journal-title":"Science"},{"key":"33","doi-asserted-by":"crossref","first-page":"9161","DOI":"10.1523\/JNEUROSCI.3422-04.2004","article-title":"Group I metabotropic glutamate receptor NMDA receptor coupling and signaling cascade mediate spinal dorsal horn NMDA receptor 2B tyrosine phosphorylation associated with inflammatory hyperalgesia","volume":"24","author":"Ren","year":"2004","journal-title":"J Neurosci"},{"key":"34","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1113\/jphysiol.2003.056812","article-title":"Group II metabotropic glutamate receptors enhance NMDA receptor currents via a protein kinase C-dependent mechanism in pyramidal neurones of rat prefrontal cortex","volume":"554","author":"Yan","year":"2004","journal-title":"J Physiol"},{"key":"35","doi-asserted-by":"crossref","first-page":"17194","DOI":"10.1074\/jbc.M801713200","article-title":"Activation of 5-HT2A\/C receptors counteracts 5-HT1A regulation of n-methyl-D-aspartate receptor channels in pyramidal neurons of prefrontal cortex","volume":"283","author":"Yan","year":"2008","journal-title":"J Biol Chem"},{"key":"36","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1089\/ars.2014.5993","article-title":"The sigma1 receptor engages the redox-regulated HINT1 protein to bring opioid analgesia under NMDA receptor negative control","volume":"22","author":"Garz\u00f3n","year":"2015","journal-title":"Antioxid Redox Signal"},{"key":"37","doi-asserted-by":"publisher","first-page":"35458","DOI":"10.18632\/oncotarget.6064","article-title":"The ON: OFF switch, sigma1R-HINT1 protein, controls GPCR-NMDA receptor cross-regulation: Implications in neurological disorders","volume":"6","author":"Garz\u00f3n-Ni\u00f1o","year":"2015","journal-title":"Oncotarget"},{"key":"38","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1016\/S0024-3205(01)01181-X","article-title":"Carbetapentane attenuates kainate-induced seizures via sigma-1 receptor modulation","volume":"69","author":"Ko","year":"2001","journal-title":"Life Sci"},{"key":"39","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1016\/S0024-3205(02)02309-3","article-title":"Metabolism to dextrorphan is not essential for dextromethorphan's anticonvulsant activity against kainate in mice","volume":"72","author":"Ko","year":"2003","journal-title":"Life Sci"},{"key":"40","first-page":"1","article-title":"Opioid receptor mediated anticonvulsant effect of pentazocine","volume":"52","author":"Kohli","year":"1998","journal-title":"Indian J Med Sci"},{"key":"41","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.ejmech.2014.10.053","article-title":"Carboline- and phenothiazine-derivated heterocycles as potent SIGMA-1 protein ligands","volume":"89","author":"Melnyk","year":"2015","journal-title":"Eur J Med Chem"},{"key":"42","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.neuroscience.2010.12.064","article-title":"Activation of the zeta receptor 1 suppresses NMDA responses in rat retinal ganglion cells","volume":"177","author":"Yang","year":"2011","journal-title":"Neuroscience"},{"key":"43","doi-asserted-by":"crossref","first-page":"18219","DOI":"10.1523\/JNEUROSCI.3360-13.2013","article-title":"The sigma-1 receptor interacts directly with GluN1 but not GluN2A in the GluN1\/GluN2A NMDA receptor","volume":"33","author":"Edwardson","year":"2013","journal-title":"Journal of Neuroscience"},{"key":"44","doi-asserted-by":"crossref","first-page":"1943","DOI":"10.1017\/S1461145714000029","article-title":"The calcium-sensitive Sigma-1 receptor prevents cannabinoids from provoking glutamate NMDA receptor hypofunction: implications in antinociception and psychotic diseases","volume":"17","author":"Garz\u00f3n","year":"2014","journal-title":"Int J Neuropsychopharmacol"},{"key":"45","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1016\/S0092-8674(00)81052-1","article-title":"Inactivation of NMDA receptors by direct interaction of calmodulin with the NR1 subunit","volume":"84","author":"Huganir","year":"1996","journal-title":"Cell"},{"key":"46","doi-asserted-by":"crossref","first-page":"2289","DOI":"10.1111\/j.1476-5381.2012.01942.x","article-title":"Pharmacological properties of S1RA, a new sigma-1 receptor antagonist that inhibits neuropathic pain and activity-induced spinal sensitization","volume":"166","author":"Portillo-Salido","year":"2012","journal-title":"Br J Pharmacol"},{"key":"47","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/j.neuropharm.2014.10.022","article-title":"HINT1 protein: a new therapeutic target to enhance opioid antinociception and block mechanical allodynia","volume":"89","author":"S\u00e1nchez-Bl\u00e1zquez","year":"2015","journal-title":"Neuropharmacology"},{"key":"48","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1111\/j.1476-5381.1989.tb14637.x","article-title":"Convulsions induced by centrally administered NMDA in mice: effects of NMDA antagonists, benzodiazepines, minor tranquilizers and anticonvulsants","volume":"98","author":"Prud'hon","year":"1989","journal-title":"Br J Pharmacol"},{"key":"49","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1007\/BF02259102","article-title":"Comparative analysis of seizures induced by intracerebroventricular administration of NMDA, kainate and quisqualate in mice","volume":"88","author":"Ungerer","year":"1992","journal-title":"Exp Brain Res"},{"key":"50","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1016\/0091-3057(88)90089-5","article-title":"Mechanisms of effects of d-fenfluramine on brain serotonin metabolism in rats: uptake inhibition versus release","volume":"30","author":"Robertson","year":"1988","journal-title":"Pharmacol Biochem Behav"},{"key":"51","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1002\/(SICI)1098-2396(200005)36:2<102::AID-SYN3>3.0.CO;2-#","article-title":"Effects of phentermine and fenfluramine on extracellular dopamine and serotonin in rat nucleus accumbens: therapeutic implications","volume":"36","author":"Rothman","year":"2000","journal-title":"Synapse"},{"key":"52","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1111\/j.1471-4159.2006.04277.x","article-title":"Serotonin and epilepsy","volume":"100","author":"Jakus","year":"2007","journal-title":"J Neurochem"},{"key":"53","doi-asserted-by":"crossref","first-page":"59","DOI":"10.2174\/1568026053386980","article-title":"Serotonergic 5-HT2C receptors as a potential therapeutic target for the design antiepileptic drugs","volume":"5","author":"Isaac","year":"2005","journal-title":"Curr Top Med Chem"},{"key":"54","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1517\/14728222.12.1.45","article-title":"An update on the development of drugs for neuropsychiatric disorders: focusing on the sigma 1 receptor ligand","volume":"12","author":"Su","year":"2008","journal-title":"Expert Opin Ther Targets"},{"key":"55","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1523\/JNEUROSCI.17-01-00011.1997","article-title":"Mu-Opioid receptors modulate NMDA receptor-mediated responses in nucleus accumbens neurons","volume":"17","author":"Siggins","year":"1997","journal-title":"Journal of Neuroscience"},{"key":"56","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/1756-6606-6-42","article-title":"HINT1 protein cooperates with cannabinoid 1 receptor to negatively regulate glutamate NMDA receptor activity","volume":"6","author":"Garz\u00f3n","year":"2013","journal-title":"Mol Brain"},{"key":"57","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1124\/jpet.109.156216","article-title":"Signaling pathways from cannabinoid receptor-1 activation to inhibition of N-methyl-D-aspartic acid mediated calcium influx and neurotoxicity in dorsal root ganglion neurons","volume":"331","author":"Cheng","year":"2009","journal-title":"J Pharmacol Exp Ther"},{"key":"58","doi-asserted-by":"crossref","first-page":"2557","DOI":"10.1046\/j.1460-9568.1998.00267.x","article-title":"Influence of Gz and Gi2 transducer proteins in the affinity of opioid agonists to mu receptors","volume":"10","author":"S\u00e1nchez-Bl\u00e1zquez","year":"1998","journal-title":"Eur J Neurosci"},{"key":"59","first-page":"1285","article-title":"Role of mPKCI, a novel mu-opioid receptor interactive protein, in receptor desensitization, phosphorylation, and morphine-induced analgesia","volume":"66","author":"Wang","year":"2004","journal-title":"Molecular Pharmacology"},{"key":"60","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1089\/ars.2012.4517","article-title":"GPCRs promote the release of zinc ions mediated by nNOS\/NO and the Redox transducer RGSZ2 protein","volume":"17","author":"Garz\u00f3n","year":"2012","journal-title":"Antioxid Redox Signal"},{"key":"61","doi-asserted-by":"crossref","first-page":"199","DOI":"10.2174\/1874473711205030199","article-title":"Direct association of Mu-opioid and NMDA glutamate receptors supports their cross-regulation: molecular implications for opioid tolerance","volume":"5","author":"S\u00e1nchez-Blazquez","year":"2012","journal-title":"Curr Drug Abuse Rev"},{"key":"62","doi-asserted-by":"crossref","first-page":"2933","DOI":"10.1007\/s00018-010-0598-x","article-title":"The histidine triad nucleotide-binding protein 1 supports mu-opioid receptor-glutamate NMDA receptor cross-regulation","volume":"68","author":"Garz\u00f3n","year":"2011","journal-title":"Cell Mol Life Sci"},{"key":"63","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1126\/science.1088208","article-title":"CB1 cannabinoid receptors and on-demand defense against excitotoxicity","volume":"302","author":"Schutz","year":"2003","journal-title":"Science"},{"key":"64","doi-asserted-by":"publisher","first-page":"55840","DOI":"10.18632\/oncotarget.10095","article-title":"Endocannabinoid control of glutamate NMDA receptors: the therapeutic potential and consequences of dysfunction","volume":"7","author":"Garz\u00f3n-Ni\u00f1o","year":"2016","journal-title":"Oncotarget"},{"key":"65","doi-asserted-by":"crossref","first-page":"e0125898","DOI":"10.1371\/journal.pone.0125898","article-title":"Pharmacological characterization of an antisense knockdown zebrafish model of Dravet syndrome: inhibition of epileptic seizures by the serotonin agonist fenfluramine","volume":"10","author":"Esguerra","year":"2015","journal-title":"PLoS One"},{"key":"66","first-page":"669","article-title":"Clemizole and modulators of serotonin signalling suppress seizures in Dravet syndrome","volume":"140","author":"Baraban","year":"2017","journal-title":"Brain"},{"key":"67","first-page":"191","article-title":"Pharmacological Analysis of the Anti-epileptic Mechanisms of Fenfluramine in scn1a Mutant Zebrafish","volume":"8","author":"Lagae","year":"2017","journal-title":"Front Pharmacol"},{"key":"68","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.2174\/0929867013372328","article-title":"The NMDA receptor complex: a promising target for novel antiepileptic strategies","volume":"8","author":"Dannhardt","year":"2001","journal-title":"Curr Med Chem"},{"key":"69","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1056\/NEJM199301073280105","article-title":"Efficacy of felbamate in childhood epileptic encephalopathy (Lennox-Gastaut syndrome)","volume":"328","author":"Felbamate Study Group in Lennox-Gastaut Syndrome","year":"1993","journal-title":"N Engl J Med"},{"key":"70","first-page":"19","article-title":"Morphine induces endocytosis of neuronal mu-opioid receptors through the sustained transfer of Galpha subunits to RGSZ2 proteins","volume":"3","author":"Garz\u00f3n","year":"2007","journal-title":"Mol Pain"}],"container-title":["Oncotarget"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.25169","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,4]],"date-time":"2025-07-04T04:40:45Z","timestamp":1751604045000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.25169"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5,4]]},"references-count":70,"journal-issue":{"issue":"34","published-print":{"date-parts":[[2018,5,4]]}},"alternative-id":["25169","29805740"],"URL":"https:\/\/doi.org\/10.18632\/oncotarget.25169","relation":{},"ISSN":["1949-2553"],"issn-type":[{"value":"1949-2553","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,5,4]]}}}